Publications of Interest > European Life Sciences > Life Sciences > Practices : Morgan, Lewis & Bockius

10/06/09 European Court of Justice Delivers Mixed Message on Parallel Trade

LawFlash/Client Alert | Antitrust LawFlash
Antitrust Practice

The European Court of Justice (ECJ) issued its long-awaited decision in C-501/06 P GlaxoSmithKline Services v. Commission today (October 6, 2009). The ECJ overturned the European Commission's (EC's or the Commission's) decisi... more

09/28/09 German Federal Cartel Office Imposes €11.5 Million Fine on CIBA Vision for Restricting Online Sales of Contact Lenses and for Resale Price Maintenance

LawFlash/Client Alert | Antitrust LawFlash
Antitrust Practice

The German Federal Cartel Office (FCO) fined U.S.-based international firm CIBA Vision €11.5 million ($16.8 million) for breaking German antitrust law by restricting online trading of its lenses and improperly pressuring on... more

09/11/09 European Court of Justice Confirms Presumption of Parent Company Liability for Subsidiaries' Antitrust Violations in Akzo

LawFlash/Client Alert | Antitrust LawFlash
Antitrust Practice

The European Court of Justice (ECJ) confirmed September 9, 2009, in Akzo Nobel and Others v. Commission (Case C-97/08 P), that parent companies are presumed to be liable for cartel violations committed by their wholly owned su... more

09/25/08 Spotlight on the EU: Documenting Compliance with Evolving Guidance When Designing Multi-Center/Country Studies and Examining Implementation Issues in Key Member States, presented at ACI's 3rd Legal and Regulatory Forum on Conducting International Clinical Trials, Boston

Presentation | Speech
Anthony Warnock-Smith

09/18/08 European Court of Justice Finds Dominant Pharma Companies May Not Prevent Parallel Imports by Refusing to Meet “Ordinary” Orders from Wholesalers

LawFlash/Client Alert | Antitrust LawFlash
Antitrust Practice

The European Court of Justice (ECJ) ruled on September 16 that pharmaceutical companies that occupy a dominant position with respect to a particular drug may not refuse to meet “ordinary” orders from wholesalers in o... more

July 2008 Advanced Therapies Regulation, European BioPharmaceutical Review

Outside Publication | Article
Anthony Warnock-Smith

06/19/08 From Europe and Japan to the U.S.: Build or Buy?, presented at the 2008 BIO International Convention, San Diego, CA

Presentation | Speech
Randall Sunberg

May 2007 Bringing a Drug to Market in the EU Using the New Decentralised Procedure, Euralex

Outside Publication | Article
Anthony Warnock-Smith

Spring 2007 The Legal Implications of Phase I Clinical Trials, European BioPharmaceutical Review Spring 07

Outside Publication | Article
Anthony Warnock-Smith

2 November 2006 Defective Defence, Legal Week

Outside Publication | Article
Anthony Warnock-Smith

2005 The Self-Regulation of Medicines in the UK (Chapter 3), The International Comparative Legal Guide to Pharmaceutical Advertising 2005

Outside Publication | Chapter
Anthony Warnock-Smith